1.Nihon Yakurigaku Zasshi. 2013 Jul;142(1):39-46. doi: 10.1254/fpj.142.39. Pharmacological and clinical properties of AIMIX combination tablets LD&HD, fixed-dose combination of irbesartan and amlodipine besilate. 2.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 3.Clin Ther. 2012 Aug;34(8):1705-19. doi: 10.1016/j.clinthera.2012.06.026. Epub 2012 Jul 30. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 4.Clin Ther. 2012 Aug;34(8):1720-34.e3. doi: 10.1016/j.clinthera.2012.07.001. Epub 2012 Jul 30. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 5.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 6J Cardiol. 2019 Mar 20. pii: S0914-5087(19)30053-X. doi: 10.1016/j.jjcc.2019.03.001. [Epub ahead of print] Arginine vasopressin antagonism in heart failure: Current status and possible new directions. Goldsmith SR1. 7.Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability 8.Expert Rev Neurother. 2017 Jan;17(1):59-75. Epub 2016 Oct 20. Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology. Tramutola A1, Arena A1,   [更多]

求購<71> Sterility Tests《USP43-NF38》的藥典標(biāo)準(zhǔn)一份   [更多]

如題，求購熊去氧膽酸膠囊BP2017或以上更新的標(biāo)準(zhǔn)，有更新的最好   [更多]

    求購葡萄糖酸鈣氯化鈉注射液過一評的質(zhì)量質(zhì)量信息   [更多]

求購Rosuvastatin Calcium《USP–NF 2021(Issue 2)》的藥典標(biāo)準(zhǔn)一份； 求購瑞舒伐他汀鈣 片 最新USP43-NF38 或《USP–NF 2021(Issue 2)》藥典標(biāo)準(zhǔn)一份；   [更多]

求購硫酸魚精蛋白Protamine sulfate《EP10.8》的藥典標(biāo)準(zhǔn)一份   [更多]

利伐沙班最新歐洲藥典中對映異構(gòu)體所用的色譜柱的具體型號，及檢測方法。   [更多]

請求這個藥品的具體質(zhì)量指標(biāo)參數(shù)   [更多]

需要詳細的標(biāo)準(zhǔn)以及檢測方法，有跟其他國家的對比的更好   [更多]

標(biāo)題：重金求購Calcium gluconate for injection《EP10.2》、USP43、BP藥典標(biāo)準(zhǔn)一份 詳細要求：Calcium gluconate for injection《EP10.2》》、USP43、BP藥典標(biāo)準(zhǔn)各一份 交稿方式：直接點擊交稿在線交稿就是了，我會每天過來看的，謝謝各位藥智的戰(zhàn)友們   [更多]